Page last updated: 2024-10-27

flumazenil and Heritable Pulmonary Arterial Hypertension

flumazenil has been researched along with Heritable Pulmonary Arterial Hypertension in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tenorio, J1
Navas, P1
Barrios, E1
Fernández, L1
Nevado, J1
Quezada, CA1
López-Meseguer, M1
Arias, P1
Mena, R1
Lobo, JL1
Alvarez, C1
Heath, K1
Escribano-Subías, P1
Lapunzina, P1

Other Studies

1 other study available for flumazenil and Heritable Pulmonary Arterial Hypertension

ArticleYear
A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies.
    Clinical genetics, 2015, Volume: 88, Issue:6

    Topics: Adolescent; Adult; Base Sequence; Familial Primary Pulmonary Hypertension; Female; Founder Effect; G

2015